Borhan B, Murray AM, Saei AA, Ghaffari B, Jackson JE, Mohammed N, Mitchell MJ, Vali H, Whitehead KA, Mahmoudi M. Influence of protein aggregates, extracellular vesicles, and lipoprotein fusion on ionizable lipid nanoparticles protein corona analysis. Nat Commun. 2026 06 12; 17(1).

Lundby A, Van Eyk JE, Mayr M, White MY, Kirk JA, Achter JS, Fert-Bober J, Wierer M, Mertins P, Lam MPY, Humphrey SJ, Lau E, Gramolini AO, Ge Y, Gundry RL. Consensus statement on mass spectrometry-based proteomic analysis of cardiac tissue. Nat Cardiovasc Res. 2026 Jun; 5(6):526-540.

Zöller M, Mastalerz M, Dick E, Merl-Pham J, Hennen E, Prakki SRS, Chakraborty A, Nakayama M, Klotz M, Marchi H, LeGleut R, De Sadeleer LJ, Wuyts WA, Vanaudenaerde BM, Jeridi A, Prasse A, Jäger B, Santofimia-Castaño P, Stoleriu MG, Hilgendorff A, Hauck SM, Yildirim AÖ, Schiller H, Staab-Weijnitz CA. Nuclear protein 1 is a cell death regulator in primary human airway epithelial cells and reduced in idiopathic pulmonary fibrosis. Sci Rep. 2026 May 11; 16(1).

Bhargava M, Crouser ED, Barkes BQ, Weise DO, Perlman DM, Epperson LE, Griffin TJ, Jagtap PD, Mehta S, Li L, Leach SM, Maier LA. Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression. BMJ Open. 2026 Apr 29; 16(4):e119604.

Bhargava M, Weise DO, Barkes BQ, Jagtap PD, Mehta S, Lock EF, Kakoty B, Perlman DM, Dincer EH, Restrepo CI, Griffin TJ, Fingerlin TE, Li L, King-Biggs M, Maier LA. Comprehensive proteomic classifier for molecular characterisation of pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to evaluate bronchoalveolar fluid and cell diagnostic and prognostic biomarkers of pulmonary sarcoidosis. BMJ Open. 2026 Apr 28; 16(4):e118207.

Moolhuijsen LME, Zhu J, Mullin BH, Pujol-Gualdo N, Actkins KV, Mack JA, Rao H, Trivedi B, Kentistou KA, Zhao Y, Westergaard D, Tyrmi JS, Thorleifsson G, Zhang Y, Wittemans L, DeVries A, Brewer K, Sisk R, Danning R, Preuss MH, Jones MR, Ruth KS, Andersen M, Azziz R, Banasik K, Boehnke M, Broer L, Brunak S, Chan YM, Chasman DI, Daly M, Ehrmann DA, Fauser BC, Fritsche LG, Hayes MG, He C, Huang H, Kowalska I, Kraft P, Legro RS, Lin N, Loos RJ, Louwers YV, Magi R, McCarthy MI, Morin-Papunen L, Morrison JV, Morton C, Nadkarni GN, Neale BM, Nielsen HS, Nyegaard M, Ostrowski SR, Pedersen OBV, Sørensen E, Mikkelsen C, Erikstrup C, Kaspersen KA, Bruun MT, Aagaard B, Ullum H, Obermayer-Pietsch B, Palotie A, Reeve MP, Salumets A, Saxena R, Spector TD, Stuckey BGA, Thorsteinsdottir U, Uitterlinden AG, Urbanek M, Zöllner S, van Heel DA, Hirschhorn JN, Stefansson K, Perry JRB, Styrkarsdottir U, Wilson SG, Piltonen T, Laisk T, Jarvelin MR, Burns K, Justice AE, Laivuori H, Ong KK, Goodarzi MO, Davis LK, Dunaif A, Lindgren CM, Laven JSE, Franks S, Visser JA, Welt CK, Karaderi T, Day FR. Genomic analyses implicate hormonal and metabolic dysregulation in polycystic ovary syndrome. Nat Genet. 2026 May; 58(5):1040-1050.

Zhang K, Chen J, Yan Y, Wang H, Miao Z, Gou W, Xiao C, Shi R, Jia X, Du W, Huang Y, Guo T, Su C, Fu Y, Chen YM, Zheng JS. Longitudinal multimorbidity trajectories shape personalized glycaemic patterns. Nat Metab. 2026 May; 8(5):1229-1245.

Goel K, Ormesher R, Pratte KA, Wang Y, Nishino K, Hersh CP, Kechris K, Bowler RP, Petrache I. Vascular-related proteomic signatures in COPD with suspected pulmonary hypertension as predictors of FEV1 impairment. Respir Res. 2026 Mar 28; 27(1).

Asokan S, Zhou W, Fringuello A, Pointon T, Kennedy A, Freitas B, Tumas French J, Zhao H, Coughlan C, Alvarez E, Yu X. CNS-compartmentalized IgG aggregates and glycosylation in multiple sclerosis contribute to oligoclonal bands and neuronal cytotoxicity. Front Immunol. 2026; 17:1689835.

So K, Saferali A, Yun JH, Ryu MH, Schiavi E, Castaldi PJ, Ruvuna L, Bowler RP, Curtis JL, Hersh CP. Blood cell ratio biomarkers of systemic inflammation in chronic obstructive pulmonary disease. Respir Res. 2026 Mar 18; 27(1).